Sleep inducers do not impact CV event, death risk

Sleep inducer prescriptions were unrelated to increased risk for mortality, major adverse CV events and HF events in patients at a CV hospital, researchers reported in theEuropean Journal of Preventive Cardiology.

“Cardiovascular diseases or concomitant cardiovascular risks are major reasons for prescribing pharmacological sleep inducers as they may trigger insomnia through anxiety or polypharmacy,” Emi Fujii, MD, of the department of cardiovascular medicine at the Cardiovascular Institute in Tokyo, and colleagues wrote. “This study investigated the association between sleep inducer prescriptions and the prognosis of patients visiting a cardiovascular hospital.” Read more in Healio.